Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec 25;4(1):1-17.
doi: 10.3390/antibiotics4010001.

The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia

Emilio Bouza  1   2   3 , Jesús Guinea  4   5 , María Guembe  6
Affiliations
Review

The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia

Emilio Bouza et al. Antibiotics (Basel). .

Abstract

Catheter-related bloodstream infection (C-RBSI) is one of the most frequent nosocomial infections. It is associated with high rates of morbidity and mortality. Candida spp. is the third most common cause of C-RBSI after coagulase-negative staphylococci and Staphylococcus aureus and is responsible for approximately 8% of episodes. The main cause of catheter-related candidemia is the ability of some Candida strains-mainly C. albicans and C. parapsilosis-to produce biofilms. Many in vitro and in vivo models have been designed to assess the activity of antifungal drugs against Candida biofilms. Echinocandins have proven to be the most active antifungal drugs. Potential options in situations where the catheter cannot be removed include the combination of systemic and lock antifungal therapy. However, well-designed and -executed clinical trials must be performed before firm recommendations can be issued.

Keywords: Candida; antifungals; biofilm; catheter-related candidemia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Crump J.A., Collignon P.J. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 2000;19:1–8. - PubMed
    1. Weinberger M., Leibovici L., Perez S., Samra Z., Ostfeld I., Levi I., Bash E., Turner D., Goldschmied-Reouven A., Regev-Yochay G., et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J. Hosp. Infect. 2005;61:146–154. - PubMed
    1. Velasco E., Bigni R. A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur. J. Clin. Microbiol. Infect. Dis. 2008;27:1071–1078. doi: 10.1007/s10096-008-0546-y. - DOI - PubMed
    1. Ferreira A.V., Prado C.G., Carvalho R.R., Dias K.S., Dias A.L. Candida albicans and non-C. albicans Candida species: Comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia. 2012;175:265–272. doi: 10.1007/s11046-013-9638-z. - DOI - PubMed
    1. Goldmann D.A., Pier G.B. Pathogenesis of infections related to intravascular catheterization. Clin. Microbiol. Rev. 1993;6:176–192. - PMC - PubMed

LinkOut - more resources